0.8915
Agilon Health Inc (AGL) 最新ニュース
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know - Yahoo Finance
Why agilon health inc. stock attracts strong analyst attentionDay Trading Setup Forecast with Trend Model - Newser
Agilon Health, Inc. (NYSE:AGL) Shares Purchased by XTX Topco Ltd - Defense World
Is a relief rally coming for agilon health inc. holdersShort-Term Profit Alert With Entry Forecast - Newser
Agilon Health's Leadership Crisis and Earnings Withdrawal: A Wake-Up Call for Investors - AInvest
Agilon Health Under Investigation for Securities Fraud Violations - AInvest
agilon health, inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Agilon Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
agilon health, inc. (AGL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
A Closer Look at Agilon Health Inc (AGL) Stock Gains - investchronicle.com
Fibonacci Levels Suggest Recovery for agilon health inc.Capital Preserving Trade Plan Templates Shared - beatles.ru
Published on: 2025-08-11 04:07:55 - Newser
Using AI based signals to follow agilon health inc.Weekly Portfolio Update with ROI Focus - Newser
Earnings visualization tools for agilon health inc.Equity Forecast with Predictive AI Screener - Newser
Visual trend scoring systems applied to agilon health inc.Growth Projection Summary for Long-Term Investors - Newser
agilon health, inc. (AGL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Should you wait for a breakout in agilon health inc.Intraday Strategy with Real Time Monitoring - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against agilon health, inc. (AGL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Can agilon health inc. recover in the next quarterFree Access to Real-Time Trade Insights - Newser
Barclays Lowers Agilon Health (NYSE:AGL) Price Target to $1.50 - Defense World
Agilon Health Q3 EPS Estimate Decreased by Leerink Partnrs - Defense World
Agilon Health, Inc. (NYSE:AGL) Q2 2025 Earnings Call Transcript - Insider Monkey
agilon health, inc. (NYSE:AGL) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
agilon health CEO steps down; interim lead appointed - MSN
Agilon Health, Inc. (NYSE:AGL) Given Consensus Rating of “Hold” by Analysts - Defense World
Agilon Health’s Earnings Call: Challenges and Optimism - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc.AGL - PR Newswire
Agilon Health Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - TradingView
Agilon Health CEO Resignation and Earnings Guidance Suspension - MSN
agilon health Second Quarter 2025 Earnings: Misses Expectations - simplywall.st
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates - MSN
Citigroup Downgrades agilon health to Neutral From Buy, Adjusts Price Target to $1 From $3 - MarketScreener
Citigroup Downgrades Agilon Health to Neutral From Buy, Adjusts Price Target to $1 From $3 - 富途牛牛
agilon health, inc. Securities Lawsuit Investigation - Claim Depot
Agilon Health (NYSE:AGL) Sets New 1-Year Low Following Weak Earnings - Defense World
Agilon Health Reports Q2 2025 Results Amid Leadership Change - TipRanks
Agilon Health's Q2 2025: Key Contradictions in Growth Strategy, Risk Assessment, and Cost Management - AInvest
agilon health, inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:AGL) - Seeking Alpha
Agilon Health (AGL): Navigating Near-Term Turbulence for Long-Term Value Realization - AInvest
Agilon Health downgraded to Neutral from Buy at Citi - TipRanks
Capital World Investors Has $920.77 Million Stake in Agilon Health, Inc. (NYSE:AGL) - 富途牛牛
Agilon Health Inc (AGL) Q2 2025 Earnings Call Highlights: Strategic Initiatives and Challenges ... By GuruFocus - Investing.com Canada
agilon health inc reports results for the quarter ended June 30Earnings Summary - TradingView
Agilon Health (AGL.N) Suffers Unprecedented Intraday Drop—What's Behind the Crash? - AInvest
AGL Stock Alert: agilon health CEO Resigns; agilon Suspends Full Year 2025 Earnings GuidanceKehoe Law Firm, P.C. Investigating Potential Securities Claims - ACCESS Newswire
Agilon Health Plummets 51%—What’s Driving the Sharp Intraday Move? - AInvest
Agilon Health Missed Financial Targets And Pulled Its Forecast - Finimize
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against agilon health, inc. (AGL) And Encourages Stockholders to Reach Out - ACCESS Newswire
Johnson Fistel Commences Investigation of Agilon Health, Inc. - GlobeNewswire
Nasdaq Down 50 Points; ISM Services PMI Declines In JulyAmeresco (NYSE:AMRC), Agilon Health (NYSE:AGL) - Benzinga
Why agilon health (AGL) Stock Is Falling Today - TradingView
INVESTOR ALERT: Investigation of agilon health, inc. (AGL) Announced by Holzer & Holzer, LLC - GlobeNewswire
Agilon Health’s Hold Rating Amid CEO Resignation and Earnings Shortfall - TipRanks
Agilon Health Investigated For Securities Fraud; Block & Leviton Encourages Investors to Contact The Firm To Potentially Recover Losses - ACCESS Newswire
Dow Surges Over 100 Points; Pfizer Earnings Top Views - Benzinga
Optimistic Buy Rating for Agilon Health Amid Strategic Initiatives and Future Prospects - TipRanks
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $4 to $4 - 富途牛牛
Agilon Health’s Tumultuous Shifts: Time to Review? - timothysykes.com
大文字化:
|
ボリューム (24 時間):